| E2641 |
trans-Chalcone
|
Trans-Chalcone, the backbone of flavonoids, also is a potent fatty acid synthase (FAS) with IC50 of 17.1 μg/mL, and α-amylase inhibitor, causes cellcycle arrest and induces apoptosis in the breastcancer cell line MCF-7, exerting antifungal and anticancer activities.
|
|
|
| E2667 |
IPI-9119
|
IPI-9119 is a potent, selective, and irreversible inhibitor of fatty acid synthase (FASN), which can inhibit the FASN thioesterase domain by promoting acylation of the catalytic serine with an IC50 of 0.3 nM.
|
|
|
| S6466 |
Eicosapentaenoic acid ethyl ester
|
Eicosapentaenoic acid ethyl ester (AMR101, EPA ethyl ester, Ethyl eicosapentaenoate) is an omega-3 fatty acid agent that significantly reduces the triglyceride (TG) levels and improves other lipid parameters without significantly increasing the low-density lipoprotein (LDL) cholesterol levels.
|
|
|
| S3576 |
TVB-3166
|
TVB-3166 is an orally-available, reversible, potent and selective inhibitor of fatty acid synthase (FASN) with IC50 of 0.042 μM in an in vitro biochemical assay. This compound induces apoptosis, and inhibits in-vivo xenograft tumor growth.
|
|
|
| S6248 |
Fasnall
|
Fasnall, a thiophenopyrimidine, is a selective fatty acid synthase (FASN) inhibitor that shows potent anti-tumor activity.
|
|
|
| S2697 |
A-769662
|
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM in cell-free assays, little effect on GPPase/FBPase activity.
|
-
FEBS J, 2025, 10.1111/febs.70247
-
Arch Biochem Biophys, 2025, 769:110433
-
J Clin Invest, 2024, 134(22)e181314
|
|
| S2250 |
EGCG ((-)-Epigallocatechin Gallate)
|
EGCG ((-)-Epigallocatechin Gallate) is the main catechin extraction of green tea that inhibits telomerase and DNA methyltransferase. EGCG blocks the activation of EGF receptors and HER-2 receptors. ECGG inhibits fatty acid synthase and glutamate dehydrogenase activity.
|
-
Clin Mol Hepatol, 2025, 10.3350/cmh.2024.0694
-
Cell Rep, 2025, 44(6):115799
-
Front Pharmacol, 2024, 15:1403424
|
|
| S2314 |
Kaempferol
|
Kaempferol, a natural flavonol, functions as an ERRα and ERRγ inverse agonist. It inhibits topoisomerase I catalyzed DNA religation and may also inhibit the activity of fatty acid synthase.
|
-
BMC Pharmacol Toxicol, 2025, 26(1):167
-
Int J Mol Sci, 2023, 24(19)14519
-
Front Pharmacol, 2023, 14:1047184
|
|
| S1629 |
Orlistat
|
Orlistat is a general lipase inhibitor with IC50 of 122 ng/ml for PL from human duodenal juice. This compound treatment reduces proliferation, induces apoptosis and arrests cell cycle.
|
-
Cell Rep, 2025, 44(7):115901
-
Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01477-y
-
J Cell Sci, 2024, 137(20)jcs262162
|
|
| S8284 |
Fatostatin HBr
|
Fatostatin HBr is an inhibitor of sterol regulatory element binding protein (SREBP). It impairs the activation of SREBP-1 and SREBP-2.
|
-
Cancer Commun (Lond), 2025, 10.1002/cac2.70038
-
Cell Commun Signal, 2025, 23(1):438
-
ACS Omega, 2024, 9(47):47042-47051
|
|